Abstract: Large-scale, integrated biobanks like the UK Biobank have completely revolutionized modern healthcare research by linking massive genetic databases with electronic health records. Unfortunately, a major blind spot persists in global biomedical discovery: despite representing a quarter of the world’s population, South Asia accounts for a mere 0.2% of participants in global genome-wide association studies. When regional scientists attempt to research widespread chronic conditions like diabetes, they are forced to work with small, fragmented institutional datasets or rely heavily on data derived from non-South Asian populations. This severe lack of representation means that as the global revolution in precision medicine moves forward, nearly two billion people risk being left behind with medical solutions that were never designed for their unique genetic background.
To dismantle this disparity, public health experts are proposing the establishment of a federated South Asia Biobank Consortium. Rather than forcing a single, rigid cross-border project, this model advocates for coordinated national biobanks that use harmonized sample protocols while utilizing advanced federated analytics to allow cross-border research without moving raw patient data across sensitive national boundaries. This technical blueprint protects national data sovereignty while simultaneously scaling up the region’s immense statistical power to track rare diseases and environmental exposures. Backed by culturally adaptive consent models, community advisory boards, and strict data-privacy layers, this coordinated initiative will transform South Asia from a peripheral participant into a powerful global engine for medical equity and life-saving scientific discovery.
Sounds Interesting? Read the full article here: https://www.sciencedirect.com/science/article/pii/S2772368226000624
